NCT07062198: Combined Metabolic Activator Supplementation in Subjects Diagnosed With Alzheimer's Disease
- State
- Under way
- Phase
- Phase 3
- People
- 845 planned
- Started
- 12 Sep 2025
- Primary completion
- Sep 2026
- Arms
- Treatment Arm
- Results
- None posted
- 14 Jul 2025: Trial registered
- 12 Sep 2025: Trial started